Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Upadacitinib |
Trade Name | Rinvoq |
Synonyms | ABT 494|ABT-494 |
Drug Descriptions |
Rinvoq (upadacitinib) is an inhibitor of JAK1 and JAK3, which may lead to decreased cell proliferation (PMID: 31976485). Rinvoq (upadacitinib) is FDA approved for rheumatoid arthritis (FDA.gov). |
DrugClasses | JAK1 Inhibitor 9 JAK3 Inhibitor 6 |
CAS Registry Number | 1310726-60-3 |
NCIT ID | C152802 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Upadacitinib | Upadacitinib | 3 | 0 |